Japan Exchange
10:17:51 2024-04-17 pm EDT
5-day change
1st Jan Change
5,170
JPY
+0.39%
-3.18%
+0.58%
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2019
August 13, 2019 at 04:19 am EDT
Noevir Holdings Co., Ltd. expected to pay dividend of JPY 180 per share for the year ending September 30, 2019 compared to JPY 180 per share a year ago.
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024
Nov. 07
CI
Noevir Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended September 30, 2023, Payable on December 11, 2023
Nov. 07
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024
Nov. 07
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023
23-08-07
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024
23-08-07
CI
Noevir Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023
23-05-10
CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023
23-05-10
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023
23-05-10
CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023
23-02-07
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
23-02-07
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
22-11-10
CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023
22-11-10
CI
Noevir Holdings Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended September 30, 2022, Payable on December 09, 2022
22-11-10
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022
22-08-04
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2022
22-08-04
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022
22-05-11
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022
22-05-11
CI
Noevir Holdings Co., Ltd. Provides Earnings Guidance for the Six Months Ending March 2022 and for the Year Ending September 2022
22-02-08
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022
22-02-08
CI
FACTBOX-Japanese companies opening COVID-19 vaccination sites amid slow national rollout
21-06-04
RE
An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. from Takashi Okura.
20-08-02
CI
Noevir Holdings Co., Ltd. Announces Distribution
19-11-18
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2019
19-08-13
CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending September 30, 2019
19-08-13
CI
Noevir Holdings Co., Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2018; Provides Earnings Forecast for the Half Year of the Fiscal Year Ending Sept. 30, 2019; Provides Earnings Forecast for the Full Year of the Fiscal Year Ending Sept. 30, 2019; Provides Dividend Forecast for the Fourth Quarter of Fiscal Year Ending Sept. 30, 2019
19-02-11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
More about the company
Last Close Price
5,150
JPY
Average target price
5,730
JPY
Spread / Average Target
+11.26%
Consensus
1st Jan change
Capi.
+0.58% 1.15B -7.19% 236B +6.84% 18.82B 0.00% 16.37B -4.40% 10.46B -14.41% 9.69B -2.00% 6.05B +1.71% 5.52B -3.79% 4.3B -14.14% 4.01B
Cosmetics & Perfumes
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
NOEVIR HOLDINGS CO., LTD. 
